RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ) (RSLBF) Stock Overview
Explore RaySearch Laboratories AB (publ)’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
46.77
EPS (TTM)
$0.67
ROE
0.26%
RSLBF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of RaySearch Laboratories AB (publ) (RSLBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $34.57.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 46.77 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
Johan Lof
416
Sveavägen 44, Stockholm
2015